bretylium tosylate

bretylium tosylate

(brĕ-tĭ′lē-ŭm tŏs′ĭ-lāt″)
An antiarrhythmic and antihypertensive drug used infrequently to manage refractory ventricular fibrillation and ventricular tachycardia.
Medical Dictionary, © 2009 Farlex and Partners

bretylium tosylate

A drug used to help to restore normal heart rhythm in the form of cardiac arrest known as VENTRICULAR FIBRILLATION. A brand name is Bretylate.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
References in periodicals archive ?
M2 EQUITYBITES-January 10, 2019-Pii wins US FDA's approval for Bretylium Tosylate Injection for ventricular fibrillation
cGMP manufacturing services company Pharmaceutics International Inc (Pii) reported on Wednesday the receipt of the US FDA approval for Bretylium Tosylate Injection in USP 500 mg/10 mL (50 mg/mL) Single-Dose Vials for the treatment of ventricular fibrillation.
The company said Bretylium Tosylate Injection is indicated for the prophylaxis and therapy of ventricular fibrillation as well as for the treatment of life-threatening ventricular arrhythmia that has failed to respond to first-line antiarrhythmic agents.
Global Banking News-January 10, 2019-Pii wins US FDA's approval for Bretylium Tosylate Injection for ventricular fibrillation
M2 PHARMA-January 10, 2019-Pii wins US FDA's approval for Bretylium Tosylate Injection for ventricular fibrillation
Academic Pharmaceuticals, Inc., a partner with Hunt Valley-based Pharmaceutics International Inc., received FDA approval to develop Bretylium Tosylate Injection USP, 500 mg/10 mL (50 mg/mL) Single-Dose Vials.
Bretylium Tosylate Injection is indicated for the prophylaxis and therapy of ventricular fibrillation; treatment of life-threatening ventricular arrhythmia that has failed to respond to first-line antiarrhythmic agents.
drugs, all in prefilled syringes: Dextrose, 50 percent; Sodium Bicarbonate; Bretylium Tosylate; Atropine, Epinephrine 1:10,000; Lidocaine, 2 percent; and Dextrose, 5 percent.
M2 EQUITYBITES-January 10, 2019-Academic Pharmaceuticals receives FDA approval for Bretylium Tosylate Injection
Academic Pharmaceuticals Inc, the partner of Pharmaceutics International Inc, has received US Food and Drug Administration (FDA) approval for Bretylium Tosylate Injection USP, 500mg/10mL (50 mg/mL) Single-Dose Vials, it was reported yesterday.
Pharmaceutics International Inc is the exclusive manufacturer of Bretylium Tosylate for Academic Pharmaceuticals Inc, which is presently seeking a commercial partner to license and launch the drug product in the US.
M2 PHARMA-January 10, 2019-Academic Pharmaceuticals receives FDA approval for Bretylium Tosylate Injection